Mereo Biopharma Group Plc
MREO
Revenue
0.00
0.000.00%
3 Months ChangeAssets
126.42M
▲63.47M▲100.83%
12 Months ChangeLiabilities
38.42M
▼-39.50M▼-50.70%
12 Months ChangeFree Cash Flow
-21.13M
▲17.70M▲45.58%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-13
Form 10-Q
ID: 0000950170-24-095777
2024-08-13
Form 8-K
ID: 0001193125-24-199430
2024-06-14
Form 8-K
ID: 0001193125-24-161662
2024-06-12
Form 8-K
ID: 0001193125-24-159393
2024-05-23
Form 8-K
ID: 0001193125-24-145983
2024-05-15
Form 10-Q
ID: 0000950170-24-060497
2024-05-15
Form 8-K
ID: 0001193125-24-139366
2024-04-15
Form 8-K
ID: 0001193125-24-095508
2024-03-27
Form 8-K
ID: 0001193125-24-078800
2024-01-08
Form 8-K
ID: 0001193125-24-003868